- •Visual Prosthetics
- •Preface
- •Acknowledgments
- •Contents
- •Contributors
- •1.1 The Visual System as an Engineering Compromise
- •1.2 An Overview of Human Visual System Architecture
- •1.2.1 Architecture and Basic Function of the Eye
- •1.2.2 Layout of the Retino-Cortical Pathway
- •1.2.3 Layout of the Subcortical Pathways
- •1.3 An Overview of Human Visual Function
- •1.3.1 Roles of Central (Foveal) Vision
- •1.3.2 Roles of Peripheral Vision
- •1.3.3 Roles of Dark-Adapted Vision
- •1.3.4 A Few Remarks Regarding Visual Development
- •1.4 Prospects for Prosthetic Vision Restoration
- •References
- •2.1 Introduction
- •2.2 Retina
- •2.2.1 Anatomy
- •2.2.2 Physiology and Receptive Fields
- •2.4.1 Anatomy
- •2.4.2 Physiology and Receptive Fields
- •2.6 The Role of Spatiotemporal Edges in Early Vision
- •2.7 The Role of Corners in Early Vision
- •2.7.1 Overview
- •2.8 Effects of Fixational Eye Movements in Early Visual Physiology and Perception
- •2.8.1 Overview
- •2.8.2 Neural Adaptation and Visual Fading
- •2.8.3 Microsaccades in Visual Physiology and Perception
- •References
- •3.1 Introduction
- •3.2 Background
- •3.3 Retinal Disease and Its Diversity
- •3.4 Retinal Remodeling
- •3.5 Retinal Circuitry
- •3.6 Retinal Circuitry Revision
- •3.7 Implications for Bionic Rescue
- •3.8 Implications for Biological Rescue
- •3.9 Final Remarks
- •References
- •4.1 Introduction
- •4.4 What Are the Limits to This Cortical Plasticity?
- •4.5 Possible Mechanisms Behind Brain Plasticity
- •4.6 Modulation of Brain Plasticity: Recent Developments
- •4.7 Neuroplasticity and Other Neuroprostheses Efforts
- •4.8 A Look at What Is Ahead
- •References
- •5.1 Introduction
- •5.2 Vision Changes Experienced by RP Patients
- •5.2.1 Overview
- •5.2.2 Visual Field Loss in RP
- •5.2.3 Changes in Color Vision and Glare Sensitivity in RP
- •5.2.4 Vision Fluctuations in RP
- •5.3 Visual Changes in Patients with Advanced Macular Degeneration
- •5.3.1 Changes Due to Wet AMD or Choroidal Neovascularization
- •5.3.2 Changes Due to Dry AMD or Geographic Atrophy
- •5.4 Charles Bonnet Syndrome
- •5.4.1 Overview
- •5.4.2 Complexity of Visual Hallucinations in CBS
- •5.4.3 Predictors and Alleviating Factors for CBS
- •5.5 Filling-In Phenomena (Perceptual Completion)
- •5.6 Remapping of Primary Visual Cortex in Patients with Central Scotomas from Macular Disease
- •5.7 The Preferred Retinal Locus for Fixation
- •5.8 Photopsias
- •5.8.1 Photopsias in RP
- •5.8.2 Photopsias in AMD and Other Ocular Diseases
- •5.9 Concluding Remarks
- •References
- •6.1 Introduction
- •6.2 Electrode–Electrolyte Interface
- •6.3 Electrode Material
- •6.3.1 Electrode Characterization
- •6.4 Overview of Electrode Materials for Neural Stimulation
- •6.5 Overview of Extracellular Stimulation
- •6.6 Safe Stimulation of Tissue
- •6.6.1 Mechanisms of Neural Injury
- •6.6.2 Parameters for Safe Stimulation
- •6.6.3 Stimulation Induced Injury in the Retina
- •References
- •7.1 Introduction
- •7.2 Power and Data Transmission
- •7.2.1 Wireline Connection
- •7.2.2 Inductive Coils
- •7.2.3 Serial Optical Telemetry
- •7.2.4 Photodiode Array-Based Prostheses
- •7.2.5 Thermal Safety Considerations
- •7.2.6 Conclusions: Comparing the Different Approaches
- •7.3 Tissue Response to a Subretinal Implant
- •7.3.1 Flat Implants
- •7.3.2 Chamber Implants
- •7.3.3 Pillar Arrays
- •7.4 Damage to Retinal Tissue from Electrical Stimulation
- •7.4.1 Effect of Pulse Duration
- •7.4.2 Electrode Size
- •7.5 Concluding Remarks
- •References
- •8.1 Introduction
- •8.2 Quasistatic Numerical Methods: The Admittance Method
- •8.2.1 Layered Retinal Model
- •8.2.2 Equivalent Electric Circuit
- •8.3 Three-Dimensional Activation Function Calculation
- •8.4 Safety of Implant
- •8.5 Conclusion
- •References
- •9.1 Pathophysiology of Retinal Degeneration
- •9.2.1 Outer Plexiform Layer
- •9.2.2 Inner Plexiform Layer
- •9.2.2.1 Bipolar Cell Excitation of Retinal Ganglion Cells
- •9.2.2.2 Amacrine Cell Modulation of Signal Processing
- •9.2.2.3 Inhibitory Transmitters
- •9.2.2.4 Acetylcholine and Dopamine
- •9.2.2.5 Neuropeptides
- •9.2.2.6 Putative neurotransmitters for retinal prosthesis
- •9.3 Neurophysiological Changes in Retinal Degeneration
- •9.4 Rationale for a Neurotransmitter-Based Retinal Prosthesis
- •9.4.1 Limitations of Electrical Stimulation
- •9.5 Technical Considerations and Design Approaches
- •9.5.1 Operating Principles for a Neurotransmitter-Based Retinal Prosthesis
- •9.5.2 Establishing a Retinal Prosthesis/Synaptic Interface
- •9.5.2.1 The Proximity Requirement
- •9.5.2.2 Convective Delivery of Neurotransmitters Via Microfluidics
- •9.5.2.3 Functionalized Surfaces for Neurotransmitter Stimulation
- •9.5.2.4 Synaptic Requirements for l-Glutamate Mediated Neuronal Stimulation
- •9.6 Summary
- •References
- •10.1 Introduction
- •10.2 Pioneering Experiments
- •10.2.1 Stimulation with No Chromophores
- •10.2.2 Azo Chromophores
- •10.3 Current Research
- •10.3.1 Caged Neurotransmitters
- •10.3.2 Pore Blocker and Photoisomerization
- •10.3.3 The Channelrhodopsins
- •10.3.4 Melanopsin
- •10.4 Synthetic Chromophores and Artificial Sight
- •References
- •11.1 Background
- •11.2 Physical Structure of Intracortical Electrodes
- •11.3 Charge Injection Using Intracortical Electrodes
- •11.3.1 The Intracortical Electrode as a Transducer
- •11.3.2 Charge Injection Limits
- •11.4 Intracortical Electrode Coatings
- •11.5 Characterization of Intracortical Electrodes
- •11.5.1 Cyclic Voltammetry
- •11.5.2 Electrode Stimulation Voltage Waveforms
- •11.5.3 Non-ideal Access Resistance Behavior
- •11.5.4 Non-linear Electrode Polarization
- •11.5.5 Determining Electrode Safety
- •11.6 Contrasts of In Vitro and In Vivo Behavior
- •11.7 Alternative Coatings for Improving Intracortical Electrodes
- •11.7.1 SIROF
- •11.7.2 PEDOT
- •11.7.3 Carbon Nanotube Coatings
- •11.8 Conclusion
- •References
- •12.1 Introduction
- •12.2 Responses of RGCs to Electrical Stimulation in Normal Retina
- •12.2.1 Epiretinal Stimulation
- •12.2.1.1 Target of Stimulation
- •12.2.1.2 The Site of Spike Initiation in RGCs
- •12.2.1.3 Threshold vs. Stimulating Electrode Diameter
- •12.2.1.4 Spatial Extent of Activation
- •12.2.1.5 Selective Activation
- •12.2.1.6 Temporal Response Properties
- •12.2.2 Subretinal Stimulation
- •12.2.2.1 Target of Stimulation
- •12.2.2.2 Threshold vs. Polarity of Stimulation Pulse
- •12.2.2.3 Spatial Extent of Activation
- •12.2.2.4 Temporal Response Properties
- •12.2.2.5 Dynamics of the Retinal Response
- •12.4 Responses of RGCs to Electrical Stimulation in Degenerate Retina
- •12.4.1 Epiretinal Stimulation
- •12.4.2 Subretinal Stimulation
- •12.4.2.1 Response Properties of RGCs
- •12.4.2.2 Activation Thresholds of RGCs
- •12.5 Cortical Responses to Retinal Stimulation
- •12.5.1 Spatial Properties Revealed by Cortical Measurements
- •12.5.2 Local Field Potentials
- •12.5.3 Elicited Responses Are Focal
- •12.5.4 Cortical Measurements Reveal Electrode Interactions
- •12.5.5 Temporal Responsiveness in Cortex
- •12.6 Suggestions for Future Studies
- •References
- •13.1 Introduction
- •13.2 General Considerations for Acute Retinal Stimulation Experiments
- •13.3 Surgical Technique
- •13.4 Threshold Measurements
- •13.5 Spatial Resolution and Pattern Perception
- •13.6 Temporal Resolution
- •13.7 Subretinal Versus Epiretinal Stimulation
- •13.8 Less Invasive Stimulation Procedures
- •13.9 Conclusions and Outlook
- •References
- •14.1 Introduction
- •14.2 Overview of Chronic Retinal Implant Technologies
- •14.2.1 The Retinal Implant AG Microphotodiode Prosthesis
- •14.2.2 The Intelligent Retinal Implant System
- •14.2.3 Second Sight Medical Products, Inc. A16 System
- •14.3 Thresholds on Individual Electrodes
- •14.3.1 Single Pulse Thresholds Using the SSMP System
- •14.3.2 Pulse Train Integration and Temporal Sensitivity
- •14.4 Suprathreshold Brightness
- •14.4.1 Brightness Using the Retinal Implant AG System
- •14.4.2 Brightness Using the Intelligent Medical Implant System
- •14.4.3 Brightness Using the SSMP A16 System
- •14.5 Spatial Vision
- •14.5.1 Spatial Vision with the Retinal Implant AG System
- •14.5.2 Spatial Vision with the Intelligent Medical Implant System
- •14.5.3 Spatial Vision with the SSMP A16 System
- •14.6 Models to Guide Electrical Stimulation Protocols
- •14.7 Conclusions
- •References
- •15.1 Background
- •15.2 Cortical Surface Stimulation
- •15.3 Intracortical Microstimulation
- •15.4 Optic Nerve Stimulation
- •15.5 What Is Known and What Needs to Be Done
- •15.6 Current Research Efforts
- •15.6.1 Optic Nerve Stimulation
- •15.6.2 Cortical Surface Stimulation
- •15.6.3 Intracortical Stimulation of Visual Cortex
- •15.6.4 CORTIVIS Program
- •15.6.5 Lateral Geniculate Stimulation
- •15.7 Microelectrode Arrays and Stimulation Hardware
- •15.7.1 Miniature Cameras
- •15.7.2 Animal Models
- •15.7.3 Image Processing and Phosphene Mapping
- •15.8 Conclusion
- •References
- •16.1 Introduction
- •16.2 Simulation Techniques and Basic Parameters
- •16.2.1 Gaze Tracking and Image Stabilization
- •16.2.2 Filter Engine Parameters
- •16.2.2.1 Raster Spatial Properties
- •16.2.2.2 Dot Spatial Properties
- •16.2.2.3 Temporal Properties
- •16.2.2.4 Dynamic Background Noise
- •16.2.2.5 Input Filtering/Windowing, Image Enhancement
- •16.3 Optotype Resolution and Reading
- •16.3.1 Visual Acuity
- •16.3.2 Reading
- •16.4 Face and Object Recognition
- •16.5 Visually Guided Behavior
- •16.5.1 Hand–Eye Coordination
- •16.5.2 Wayfinding
- •16.6 Visual Tracking
- •16.7 Computational Simulations
- •16.8 Conclusion
- •References
- •17.1 Introduction
- •17.2 Situating Image Analysis
- •17.3 The Experimental Framework
- •17.4 Tracking a Low-Resolution Target
- •17.5 Discussion
- •17.6 Conclusion
- •References
- •18.1 Introduction
- •18.2 Representation of Visual Space on the Visual Cortex
- •18.3 Cortical Stimulation Studies
- •18.4 Variability in Occipital Cortex
- •18.5 Phosphene Map Estimation
- •18.6 Psychophysical Studies with the Estimated Maps
- •References
- •19.1 Importance of Mapping
- •19.3 The Computer Era: Refining the Pointing Method of Phosphene Mapping
- •19.4 Verbal Mapping
- •19.5 Mapping Studies Using Subject Drawings
- •19.6 Recent Simulation Studies Using Phosphene Mapping
- •19.6.1 Tactile Simulations at Shanghai Jiao Tong University
- •19.6.2 Simulations in Our Laboratory
- •19.7 Concluding Remarks on Phosphene Mapping Techniques
- •References
- •20.1 Introduction
- •20.2 Principles for Assessment of Prosthetic Vision
- •20.2.1 Experimental Design
- •20.2.2 The Importance of Pre-operative Testing
- •20.2.3 Post-operative Assessment
- •20.2.4.1 Potential Approaches
- •20.2.4.2 Avoidance of Bias
- •20.2.4.3 Criteria for Sound Testing
- •20.2.4.4 Forced Choice Procedures
- •20.2.4.5 Response Time
- •20.2.4.6 Task (Perceptual) Learning
- •20.2.4.7 Establishing Criteria for Meaningful Change
- •20.2.4.8 Light Level
- •20.3 Vision Assessment in Prosthesis Recipients: Overview
- •20.3.1 Visual Function Assessment: Overview
- •20.3.2 Visual Performance Assessment: Overview
- •20.3.2.1 Measured Visual Performance
- •20.3.2.2 Self-Reported Visual Performance
- •20.4 Visual Function Assessment
- •20.4.1 Candidate Measures
- •20.4.1.1 Contrast Sensitivity (Contrast Detection)
- •20.4.1.2 Contrast Discrimination
- •20.4.1.3 Motion Perception
- •20.4.1.4 Depth Perception
- •20.4.2 Tests Used in Prosthesis Trials
- •20.4.3 Tests that Have Been Designed for Use with Prostheses
- •20.4.4 Vision Tests for Very Low Vision
- •20.5 Visual Performance Assessment
- •20.5.1 Measured Performance
- •20.5.2 Self-Reported Performance (Questionnaires)
- •20.6 Summary
- •References
- •21.1 Concepts of Functional Vision and Rehabilitation
- •21.1.1 Application to Orientation and Mobility
- •21.1.2 Application for Activities of Daily Living
- •21.1.3 Patient Lifestyle and Expectations
- •21.1.4 Congenital and Adventitious Vision Loss
- •21.2 Evaluation and Intervention with Prosthetic Vision
- •21.2.1 Evaluation
- •21.2.2 Intervention
- •21.3 Measuring Functional Outcomes
- •21.4 The Future
- •References
- •Author Index
- •Subject Index
322 |
M.P. Barry and G. Dagnelie |
Fig. 16.2 The effect of eye movements on stimulation of the visual system in natural vision (left panel) and in prosthetic vision with an external camera, both without (center panel) and with (right panel) compensation through gaze tracking
implants, only the multi-photodiode array (MPDA) of Retina Implant AG provides this capability. For all devices with an external camera the situation can be remedied by tracking the prosthesis wearer’s eye position and presenting a corresponding shift of the image to the implant. This would be done most easily by using a wideangle camera and instantly panning the section to be presented to the prosthesis wearer in accordance with the current direction of gaze. Such accurate and instantaneous gaze tracking is not currently used, however.
Accurate prosthetic vision simulations should therefore have the ability to mimic gaze stabilization. In the diagram of Fig. 16.1 this is implemented through a pupil-tracking video camera built into the HMD, eye-tracking software (Arrington Research, Scottsdale, AZ), and a resulting offset of the filtered imagery according to the updated gaze position; typically this is done at 30 or 60 frames per second, but more rapid systems are now available.
16.2.2 Filter Engine Parameters
In order to present imagery that closely resembles what a prosthesis wearer is expected to perceive, the filtering engine needs to transform the incoming video frames according to a number of important aspects. Roughly, these can be categorized into four groups: raster spatial properties, dot spatial and temporal properties, and dynamic background noise.
16.2.2.1 Raster Spatial Properties
Typically, the experimenter will have a specific implant configuration in mind and will sub-sample the incoming image to match that configuration. For a retinal
16 Simulations of Prosthetic Vision |
323 |
implant, the electrode arrangement will most likely be rectangular and regular, although hexagonal and/or radially expanding configurations could in principle be used, in order to conform more closely to the native properties of retinal processing. In all cases the incoming image is reduced in resolution by grouping the intensity and color values within the aperture of each prospective dot position. As an example, a typical 320 × 240 pixel camera image can be down-sampled to simulate a 10 × 6 implant by dividing it into 60 rectangular subfields of 32 × 40 pixels each, and averaging the pixel values within each rectangle to yield a single value that will be represented by the simulated phosphene. Color information will typically be discarded, since only grey scale values are thought to be meaningfully conveyed.
There are several instances where a regular grid of simulated phosphenes is not an adequate representation of what the implant recipient is expected to see. Most importantly, this is the case for implants beyond the retina. Stimulation of the optic nerve, LGN, or primary visual cortex should still provide a predictable phosphene array, depending on the accuracy of electrode placement, and these irregularities can be built into the simulated phosphene map.
Even for a retinal implant there may be distortions of the regular grid. In the normal retinal anatomy the centermost fovea does not contain any secondary neurons, so many neurons at 1°–2° eccentricity in the retina will correspond to locations much closer to fixation in the visual field, and stimulating those neurons will cause an apparent contraction of the image: phosphenes will be denser immediately around the point of fixation, and correspondingly sparser in a ring at 2°–4° eccentricity. In addition, the retinal rewiring process described in Chap. 3 will cause inner retinal neurons to migrate from their original positions, and may thus convey random scatter to the perceived phosphene positions. The magnitude of both effects can be estimated, but to our knowledge have not been taken into account in simulations of a retinal prosthesis. On the other hand the crude resolution of most current prostheses, with electrode separations of approximately 2°, reduces the need for such refinements.
In addition to the overall arrangement of dots in the raster, several parameters can specify raster properties:
•Dot number: This quantity corresponds to the number of electrodes in the implant.
•Dot density: This quantity determines the center-to-center distance between dots, and is typically chosen to correspond to the inter-electrode distance of the implant. For rectangular grids it is common for density to be equal in the two perpendicular directions. Note that density is the inverse of center-to-center distance.
•Dot spacing: When viewing the dot grid one can envisage each dot as being situate at the center of a “unit cell,” and the dot may or may not fill the entire cell. For round dots in a rectangular (rather than square) grating, dot spacing will be different in the two orthogonal directions. The space between dots and the background intensity light filling that space will be further discussed under
Sect. 16.2.2.2.
324 |
M.P. Barry and G. Dagnelie |
•Grid size: This quantity has a direct relationship to the previous two; it is common for one of the three parameters to be kept constant, and study the tradeoff between the remaining two.
•Dot drop-out: A subset of electrodes in an implant may prove non-functional after implantation or lose functionality over time; this loss of function can be caused by either the implant itself or by degeneration of the tissue substrate; to model this, a subset of dots may be omitted; typically this subset is chosen at random, and not altered while testing a given subject over multiple sessions, to investigate whether adaptation may occur to this localized absence of image information.
Effects of several grid parameter changes are shown in Fig. 16.3.
16.2.2.2 Dot Spatial Properties
Phosphenes elicited by localized electrical stimulation in blind individuals have generally been described as small round dots, varying in size from a pea to a quarter at arms length, and either sharp or fuzzy in appearance; some subjects have described rings or dark dots on a lighter background, depending on the stimulus conditions. This illustrates a basic problem when rendering images in even the simplest prosthetic vision simulation. The square pixelization commonly employed to hide a person’s identity in the media (see Fig. 16.4, left panel) lend themselves to rapid image rendering and have been used extensively by one research group [16, 17, 24, 26–28], but may not be an optimal representation of what is described by patients undergoing stimulation. Other groups have spent considerable effort on
Fig. 16.3 Illustration of the effects of grid and dot parameters on the display of a text fragment with pillbox-shaped dots. All changes are relative to the “standard condition” in the center of the figure. In the top right panel grid size is changed without increasing dot size or number, whereas in the bottom left panel the dot number is changed, and in the top left panel dot size is changed while keeping the gaps separating the dots equal
16 Simulations of Prosthetic Vision |
325 |
Fig. 16.4 Examples of pixelization used in prosthetic vision simulations. In both examples a rectangular raster was used. The left panel shows a 14 × 14 cell grid with square pixelization of a face (courtesy Dr. Wentai Liu), while the right panel shows a 4 × 4 grid with Gaussian dot profile as seen by a subject in our laboratory inspecting the scoop of a spoon
the creation of model phosphenes with precisely specified spatial properties. Generally, the following parameters are specified:
•Shape: Although most phosphenes seen by patients are not perfectly round, the most common shapes used in simulations have been bright circles on a dark background, as shown by the examples in Figs. 16.3 and 16.4 (right panel).
•Profile/size: There is a variety of ways in which the light representing the intensity in the scene can be distributed across the unit cell. The most common profiles chosen are rectangular and Gaussian; the extent to which the light in one cell merges with that in neighboring cells depends on the radius of the pillbox (0.495
in the example in Fig. 16.5; hence there is no overlap in the right half of the figure) or the value of s (four values shown). If a Gaussian profile is chosen there is always some overlap, making the use of Gaussians much more computationally intensive in a real-time simulation. The increased speed of general purpose processors and the use of dedicated hardware have led to more frequent use of Gaussian profiles in recent simulations, since they correspond more closely to the reports of prosthesis wearers [22].
•Intensity/contrast:Most simulations use bright dots and modulate the peak intensity of the dots to represent local brightness in the scene, on a black background. Yet it is unlikely that prosthesis wearers will experience such high contrast percepts: Patients blind from outer retinal degenerations describe their world as grey rather than black. For this reason some simulation studies have explored the dependence of subject performance on contrast. In some cases this was done by only changing dot brightness but leaving the black background; this reduces brightness rather than contrast and has very little effect as the subject adapts to the lower light level. Increasing the background intensity, with or without a reduction in dot intensity, is an appropriate way to reduce contrast.
Some studies (e.g., Chap. 17) have modulated the radius of pillbox dots rather than their intensity, but a systematic comparison of the two methods across
